Drs. Ayşegül Yildiz and Tim Beissert join Dr. Paloma Giangrande to discuss a recent article published in Molecular Therapy Nucleic Acids by Drs. Yildiz. Beissert, and colleagues titled “Trans-amplifying RNA expressing functional miRNA mediates target gene suppression and simultaneous transgene expression”.
Are you registered for ASGCT’s 2025 Annual Meeting in New Orleans? Join us May 13-17 for the premier event in our field and save $465 as an ASGCT member. Check out the full program, plan your trip, and register for the ASGCT Annual Meeting by visiting annualmeeting.asgct.org.
In This Episode
Paloma Giangrande, PhD
Editor-in-chief of Molecular Therapy Nucleic Acids
Senior Vice President Discovery & Translational Biology, Orbital Therapeutics
Ayşegül Yildiz, PhD
Scientist of TRON’s Cardiovascular Therapeutics Group
Tim Beissert, PhD
Senior Scientist and Group Leader of TRON’s Vector Development and Gene Transfer Team

The Issue – Prepared under pressure: Navigating the due diligence process with Dr. Ralph Brandenberger
39:55

mRNA-based CAR T cell engineering with Norman Drzeniek and Niklas Kotzian
32:35

The Issue - Evolving Patient Access to CGTs via Innovation in Medicaid Reimbursement Models with Melissa Majerol
35:33